These proven market-beating stocks have declined between 12% and 64% from their highs. Consider buying the dip.

Cell And Gene Therapy Market Size and ForecastThe global cell and gene therapy market is projected to witness significant ...

It comes as no surprise that artificial intelligence remains the most promising sector for venture capital in 2025. AI ...

Joint ventures can be an ideal solution to achieving a company’s desired growth outcomes while minimizing many of the risks ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Healthcare leaders enter 2025 facing a host of pressing imperatives. They need to promote sustainable financial health, ...

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

The artificial intelligence revolution requires a ton of power, placing energy companies at the top of the list of those poised to benefit from the AI boom for decades to come. Generative AI platforms ...

Drilling Tools International's recent acquisitions enhance its global presence and technological capabilities. See why I rate ...

Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to ...

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.